Almac Diagnostics Appoints Dr Leeona Galligan as Vice President UK Operations
Craigavon, N.I., 15 February 2017 – Almac Diagnostics, the global personalised medicine company, focusing on the discovery, development and commercialisation of complex diagnostic and companion diagnostic tests, has announced the appointment of Dr. Leeona Galligan (PhD, FRCPath) to the position of Vice President, UK Operations.
In her new role, Dr Galligan will be responsible for all UK based operations including commercial biomarker discovery, CLIA/FDA compliant analytical validation, downstream clinical testing, manufacturing and shipping of clinical specimen and release of controls and reagents for registrational clinical trials. In addition, she will continue to serve as a valuable member of the Almac Diagnostics’ Executive team helping to define and implement its global business strategy.